Imaging aspects of maxillomandibular bone alterations in patients with multiple myeloma treated with bisphosphonates: A systematic review

被引:0
|
作者
Gonzaga, Amanda Katarinny Goes [1 ]
Morais, Hannah Gil de Farias [1 ]
Oliveira, Camila Dayla Melo [2 ]
Campos, Magda Lyce Rodrigues [3 ]
Diaz, Carolina Raiane Leite Dourado Maranhao [2 ]
Custodio, Marcos [4 ]
Andrade, Natalia Silva [5 ]
Santana, Thalita [2 ]
机构
[1] Univ Fed Rio Grande do Norte, Dept Dent, Natal, Brazil
[2] Ceuma Univ, Postgrad Program Dent, Sao Luis, Maranhao, Brazil
[3] Univ Maranhao, Sch Dent, Sao Luis, Brazil
[4] Univ Fed Maranhao, Sch Med, Imperatriz, Brazil
[5] Univ Fed Sergipe, Dept Dent, Lagarto, Brazil
关键词
Multiple Myeloma; Bisphosphonate; BisphosphonateAssociated Osteonecrosis of the Jaw; Diagnostic Imaging; MEDICATION-RELATED OSTEONECROSIS; ASSOCIATION; JAW;
D O I
10.5624/isd.20240032
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Purpose : Multiple myeloma (MM) is a rare cancer that is typically managed with bisphosphonates to slow bone resorption and prevent skeletal complications. This study aimed to identify imaging patterns in MM patients recei ving bisphosphonate therapy. Materials and Methods : This systematic review included studies investigating maxillomandibular bone alterations based on imaging examinations in MM patients treated with bisphosphonates. The selected studies were quali tatively assessed using the Critical Appraisal Tools from SUMARI. Results : Six studies, involving 669 MM patients, were included, with 447 receiving bisphosphonate treatment. The majority were treated with pamidronate, zoledronate, or a combination of both. Seventy patients developed medicationrelated osteonecrosis of the jaw (MRONJ), predominantly in the mandible, characterized by the presence of bony sequestrum, bone sclerosis, increased periodontal ligament space, osteolytic lesions, and osteomyelitis as observed in imaging analyses. For nonMRONJ lesions, the mandible also exhibited the highest frequency of asymptomatic bone alterations. These ranged from "punchedout" osteolytic lesions or "soap bubble" lesions to solitary bone lesions, areas of bone sclerosis, abnormalities of the hard palate, osteoporosis, nonhealed alveoli, and cortical bone rupture. Conclusion : MM patients treated with bisphosphonates display radiographic patterns of maxillomandibular bone lesions. These patterns aid in diagnosis and facilitate early and targeted treatment, thereby contributing to improved morbidity outcomes for these patients. (Imaging Sci Dent 20240032)
引用
收藏
页码:221 / 231
页数:11
相关论文
共 50 条
  • [1] Radiographic patterns of multiple myeloma in the jawbones of patients treated with intravenous bisphosphonates
    Faria, Karina Morais
    Prado Ribeiro, Ana Carolina
    Brandao, Thais Bianca
    Silva, Wagner Gomes
    Lopes, Marcio Ajudarte
    Pereira, Juliana
    Alves, Marcelo Correa
    Gueiros, Luiz Alcino
    Shintaku, Werner Harumiti
    Migliorati, Cesar Augusto
    Santos-Silva, Alan Roger
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2018, 149 (05) : 382 - 391
  • [2] Osteomylelitis and necrosis of the jaw in patients treated with bisphosphonates: a comparative study focused on multiple myeloma
    Elad, S.
    Yarom, N.
    Hamed, W.
    Ayalon, S.
    Yahalom, R.
    Regev, E.
    CLINICAL AND LABORATORY HAEMATOLOGY, 2006, 28 (06): : 393 - 398
  • [3] Osteonecrosis of the myeloma patients treated with bisphosphonates
    Capalbo, Silvana
    Franzese, Maria Grazia
    Palumbo, Gaetano
    CLINICAL CASES IN MINERAL AND BONE METABOLISM, 2007, 4 (01) : 43 - 47
  • [4] A systematic review and meta-analysis of interventional studies of bisphosphonates and denosumab in multiple myeloma and future perspectives
    Chatziravdeli, Vasiliki
    Katsaras, Georgios N.
    Katsaras, Dimitrios
    Doxani, Chrysoula
    Stefanidis, Ioannis
    Zintzaras, Elias
    JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, 2022, 22 (04) : 596 - 621
  • [5] The role of bisphosphonates for the treatment of bone disease in multiple myeloma
    Musto, P
    LEUKEMIA & LYMPHOMA, 1998, 31 (5-6) : 453 - 462
  • [6] The effect of the combination of bisphosphonates and conventional chemotherapy on bone metabolic markers in multiple myeloma patients
    Zhang, Xi
    Chang, Chunkang
    Zhao, Youshan
    Wu, Lingyun
    Zhang, Zheng
    Li, Xiao
    HEMATOLOGY, 2012, 17 (05) : 255 - 260
  • [7] Hematopoietic and microenvironment alterations in bone marrow from patients with multiple myeloma
    Mayani, Hector
    LEUKEMIA RESEARCH, 2013, 37 (02) : 228 - 229
  • [8] Risk of developing spontaneous MRONJ in fibrous dysplasia patients treated with bisphosphonates: a systematic review of the literature
    Nadella, Srighana
    Mupparapu, Mel
    Akintoye, Sunday O.
    QUINTESSENCE INTERNATIONAL, 2022, 53 (07): : 616 - 623
  • [9] Use of bisphosphonates in multiple myeloma patients in Denmark, 2005-2015
    Olesen, Tina Bech
    Andersen, Ina Trolle
    Ording, Anne Gulbech
    Ehrenstein, Vera
    Seesaghur, Anouchka
    Helleberg, Carsten
    Silkjaer, Trine
    Hernandez, Rohini K.
    Niepel, Daniela
    Abildgaard, Niels
    SUPPORTIVE CARE IN CANCER, 2021, 29 (08) : 4501 - 4511
  • [10] Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review
    Regelink, Josien C.
    Minnema, Monique C.
    Terpos, Evangelos
    Kamphuis, Marjolein H.
    Raijmakers, Pieter G.
    Pieters-van den Bos, Indra C.
    Heggelman, Ben G. F.
    Nievelstein, Rutger-Jan
    Otten, Rene. H. J.
    van Lammeren-Venema, Danielle
    Zijlstra, Josee M.
    Arens, Anne I. J.
    de Rooy, Jacky W.
    Hoekstra, Otto S.
    Raymakers, Reinier
    Sonneveld, Pieter
    Ostelo, Raymond W.
    Zweegman, Sonja
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (01) : 50 - 61